Oxytocin/Foley vs. Oxytocin for PPROM
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores the best way to induce labor for individuals experiencing preterm prelabor rupture of membranes (PPROM). Researchers compare two methods: using oxytocin (a hormone that stimulates contractions) alone and oxytocin combined with a Foley catheter (a device to help open the cervix). The goal is to determine which method leads to quicker delivery. Suitable participants have had their water break early, are between 34 to 36 weeks pregnant, and have a cervix that is not too open yet. As a Phase 4 trial, the treatment is already FDA-approved and proven effective, and this research aims to understand how it benefits more patients.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What is the safety track record for these treatments?
Research has shown that using oxytocin with a Foley catheter is generally safe for patients whose water has broken before labor begins. Studies comparing this combination to using only oxytocin to induce labor suggest that adding a Foley catheter does not significantly speed up delivery compared to just using oxytocin.
Both oxytocin and the Foley catheter are commonly used in medical settings to help start labor. Oxytocin initiates or strengthens labor contractions, while the Foley catheter, a small balloon-like device, is inserted into the cervix to help it open.
Safety data from previous studies indicate no significant increase in side effects when using both oxytocin and the Foley catheter together. This suggests that most patients tolerate the treatment well. However, like any medical procedure, risks exist, so discussing these with a healthcare provider is important.12345Why are researchers enthusiastic about this study treatment?
Researchers are excited about these treatments for preterm premature rupture of membranes (PPROM) because they offer a potentially more effective way to induce labor. Unlike the standard approach, which typically uses oxytocin alone, the experimental method combines oxytocin with a transcervical Foley catheter. This combination might enhance cervical ripening, potentially leading to a smoother and more efficient labor induction process. By exploring this combination, researchers aim to improve outcomes for both mothers and babies in cases of PPROM.
What evidence suggests that this trial's treatments could be effective for PPROM?
This trial will compare the use of Oxytocin alone with Oxytocin plus a Foley catheter for inducing labor in cases of preterm premature rupture of membranes (PPROM). Research has shown that using a Foley catheter with oxytocin might be more effective for initiating labor in full-term pregnancies, increasing the likelihood of giving birth within 24 hours compared to using oxytocin alone. However, studies on early pregnancies with premature rupture of membranes have produced mixed results. Some research suggests that the Foley catheter does not significantly accelerate delivery in these cases. While promising for full-term pregnancies, its effectiveness for early pregnancies remains unclear. This trial aims to gather more information specifically about early pregnancies.12346
Who Is on the Research Team?
Marwan Ma'ayeh, MD
Principal Investigator
Eastern Virginia Medical School
Are You a Good Fit for This Trial?
This trial is for pregnant individuals who have experienced an early rupture of their amniotic sac, known as PPROM. Specific eligibility details are not provided, but typically participants would need to be in good health with no conditions that could interfere with the study.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Induction of labor with intravenous oxytocin and a transcervical Foley catheter or oxytocin alone
Follow-up
Participants are monitored for maternal morbidity and adverse maternal outcomes
What Are the Treatments Tested in This Trial?
Interventions
- Oxytocin
- Oxytocin plus Foley Catheter
Find a Clinic Near You
Who Is Running the Clinical Trial?
Eastern Virginia Medical School
Lead Sponsor